The recent discovery that human noroviruses (huNoVs) recognize sialic acids (SAs) in addition to histo-blood group antigens (HBGAs) pointed to a new direction in studying virus-host interactions during calicivirus infection. HuNoVs remain difficult to study due to the lack of an effective cell culture model. In this study, we demonstrated that Tulane virus (TV), a cultivable primate calicivirus, also recognizes SAs in addition to the previously known TV-HBGA interactions. Evidence supporting this discovery includes that TV virions bound synthetic sialoglycoconjugates (SGCs) and that treatment of TV permissive LLC-MK2 cells with either neuraminidases or SA-binding lectins inhibited TV infectivity. In addition, we found that Maackia amurensis leukoagglutinin (MAL), a lectin that recognizes the α-2,3 linked SAs, bound LLC-MK2 cells, as well as TV, by which MAL promoted TV infectivity in cell culture. Our findings further highlight TV as a valuable surrogate for huNoVs, particularly in studying virus-host interactions that may involve two host carbohydrate receptors or co-receptors for infection.
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Attachment to a host cell receptor is the first, essential step for a virus to initiate a successful infection. The surfaces of the intestinal epithelial cells are covered by a thick layer of glycocalyx consisting of various glycans and many viral pathogens are known to recognize specific carbohydrates for attachment and entry. For example, huNoVs recognize HBGAs for attachment in a strain-specific manner [14] [15] [16] and a number of huNoV-HBGA binding profiles have been described 6, 17 . The structural bases of huNoV-HBGA interactions have been elucidated through crystallography studies [18] [19] [20] [21] , while site-directed mutagenesis experiments confirmed the HBGA-binding sites based on mutated VLP and P particle lost binding to HBGAs 18, [20] [21] [22] [23] [24] . Furthermore, the roles of huNoV-HBGA interactions in host susceptibility have been shown through human volunteer challenge studies [25] [26] [27] and huNoV outbreak investigations [28] [29] [30] [31] [32] [33] [34] . However, under in vitro conditions huNoVs cannot replicate in HBGA-expressing cell lines derived from human intestine, indicating another cell factor that is required for huNoV infection is missing. In fact, the interactions between huNoVs and non-HBGA factors have been reported. For example, earlier studies showed that huNoV VLPs interacted with heparan sulfates on the cell surface 35 and an undefined 105-kDa membrane protein 36 . In a separate study, huNoVs were found to recognize sialyl Lewis x, sialyl diLewis x, and sialylated type 2 chain conjugates 37 . Furthermore, a recent study indicated that huNoVs recognize gangliosides as ligands, in which the sialic acid (SA) components played an important role 38 . These data strongly suggest that non-HBGA factors and SA-containing sialoglycoconjugates (SGCs) may be other important host factors for huNoV infection. In this study, we provide further evidence supporting the importance of SGCs in calicivirus infection by studying an animal calicivirus, the Tulane virus, as a surrogate for huNoVs.
SGCs are major components of the surface glycocalyx of intestinal epithelial cells. SAs are typically present as outermost monosaccharides of SGCs, including glycolipids, glycoproteins, glycophospholipid anchors, and proteoglycans, which have important roles in diverse physiological and pathological processes 39 . Numerous viral pathogens are known to recognize SAs of SGCs as attachment factors or receptors for infection, including influenza virus 40, 41 , paramyxovirus 42 , reovirus 43, 44 , and picornavirus 45 . Within Caliciviridae, feline calicivirus (FCV) from the Vesivirus genus 46 , porcine sapovirus (PSaV) from the Sapovirus genus 47 , and murine norovirus (MNV) from the Norovirus genus 48 have also been shown to recognize SAs as receptors for infection, suggesting that SGCs may be commonly recognized by caliciviruses.
In addition to evidence for TV recognizing SGCs by in vitro binding experiments, we have demonstrated in this study that the infection of TV in cell cultures is significantly reduced by treatment of the host cells with either neuraminidases or SA-binding lectins. We also found that Maackia amurensis leukoagglutinin (MAL), a commercially available lectin that recognizes α -2,3 linked SAs, increased TV infectivity in cell culture. Since huNoV-SGC interactions have also been reported 37, 38 , our new data support the notion that the cultivable TV is an excellent huNoV surrogate to study huNoV-host interactions.
Materials and Methods
TV and LLC-MK2 cells. TV was originally isolated from rhesus macaque stool samples 9 ; lab stock was used in the current study. The TV-permissive cell line, LLC-MK2, is a rhesus macaque (Macaca mulatta) kidney-derived cell line that was originally purchased from ATCC (Manassas, VA). The cells were cultured in 199 medium (Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin G, and 100 μ g/mL streptomycin (Life Technologies, Grand Island, NY), at 37 °C, 5% CO2, and 100% relative humidity.
TV purification. TV was purified and quantified as described previously 13 . Briefly, LLC-MK2 cells were cultivated in rolling bottles. At about 85% confluence, cells were inoculated with 10 ml of TV inoculum (MOI = 0.4). After 60 minutes, the inoculum was replaced by 50 ml of medium without FBS. After further culture for 72 hours, the culture media were harvested by centrifugation (5,000 × g, 10 minutes) to remove cells and cell debris. The supernatants were pooled (~600 ml). TVs were pelleted down by centrifugation at 141,118 × g for 2 hours. TV pellets were resuspended in 3 to 5 mL 1x phosphate buffer saline (PBS, pH7.4). After adjustment of the TV suspension to a density of 1.365 (refractive index) with cesium chloride (CsCl), centrifugation was performed at 288,000 × g for 40 hours. The CsCl gradient was fractionated into 22 fractions through bottom puncture of the centrifugation tubes. TV containing fractions were monitored and quantified by electron microscopy (EM), SDS-PAGE, western-blot, reverse transcription-PCR (RT-PCR), and plaque assays (see below). Factions corresponding to the purified TV from a CsCl gradient containing cells/media without TV infection were also collected (designated as cell lysate) for control purpose.
TV-SGC binding assays. ELISA-based binding assays were performed using various synthetic, biotinylated SGCs. Purified TVs at a 1:40 dilution (containing TVs at ~1 × 10 4 PFU/mL), cell lysate without TV (see above) at a 1:40 dilution, recombinant HA protein (10 μ g/mL) of an H3N1 influenza virus were coated on microtiter plates overnight at 4 °C. After blocking with nonfat milk, the plates were incubated with various synthetic, biotinylated SGCs/HBGAs (1 μ g/mL) and the bound SGCs/HBGA were detected by streptavidin-HRP conjugates (Jackson Immuno Research, West Grove, PA). The signal intensity was measured using the optical density at a wavelength of 450 nm (OD 450 
, and A disaccharide (GalNAc-α 1-3-Gal) were purchased from GlycoTech (Rockville, MD). All of these oligosaccharides were conjugated with polyacrylamide (PAA) and were biotinylated. Each experiment was repeated at least four times.
TV plaque assay.
This was performed on LLC-MK2 cell monolayers in 12-well plates. Cells were seeded in the wells and incubated at 37 °C with 5% CO 2 one day prior infection. For TV infection, 0.5 mL diluted virus stock (at desired titers) was added to each well and incubated for 60 minutes on a rotating platform at 37 °C. The media were then removed and cell monolayers were washed once with PBS, and then overlaid with 1.0 mL culture media containing 0.75% agarose. The plates were further incubated at 37 °C for 3 days. The cells were then fixed with 15% formaldehyde in PBS for 15 minutes, and the cell monolayer was stained with 0.02% Crystal Violet solution (Sigma, St. Louis, MO). For blocking experiments, either TV inoculations or seeded cells were pretreated with various blocking reagents, including neuraminidases and SA binding lectins (see below), either separately or in combination, as indicated.
TV plaque assays with Lectin, and/or neuraminidase treatments. For treatment of LLC-MK2 cells with lectins, Maackia amurensis leukoagglutinin (MAL) (Sigma, St. Louis, MO) and Sambucus nigra lectin (SNL), (Sigma, St. Louis, MO) were diluted to 100 μ g/mL in 1 × PBS as stock solution. Prior to TV infection, culture media were replaced by 500 μ L of diluted lectin at indicated concentrations and incubated on a rotary shaker at 37 °C for 60 minutes in a CO 2 incubator. The mock controls were treated with 1 × PBS only. After incubation, 500 μ L of TV inoculation at desired titers were added for plaque assays (see above). The experiments were repeated for six times (N = 6). Treatment of LLC-MK2 cells with SNL or MAL at the studied concentrations did not affect the viability of the cells as monitored by microscopy.
For treatment of LLC-MK2 cells with either neuraminidase of Vibrio cholera (VCNA) or Arthrobacter ureafaciens (AUNA) (Roche, Indianapolis, IN), the enzyme was first diluted in 1 × PBS (pH5.5) with 1mM CaCl 2 , or with the dilution buffer provided by the manufacturer. Both enzymes hydrolyze terminal N-or O-acyl-neuraminic acids in α -2,3, α -2,6, or α -2,8 linkage, but preferentially cleaves α -2,3 and α -2,6 linkages, respectively, at higher rate than other linkages. Prior to TV infection, culture media were replaced by 500 μ L of neuraminidase solution at 60 mU/well. The cells were further incubated as described above on a shaker in a CO 2 incubator. The mock controls were treated with the dilution buffer only. The neuraminidase solutions were then removed and cells were washed once with PBS. TV inoculations at desired titers were added for plaque assays. The experiments were repeated for six times (N = 6). Treatment of LLC-MK2 cells with either VCNA or AUNA at the studied concentrations and conditions did not affect the viability of the cells as monitored by microscopy.
TV-lectin binding assays. Purified TV diluted 1:40 (containing TVs at ~1 × 10 4 PFU/mL) and the corresponding fraction of cell lysate without TV at the same dilution was coated on microtiter plates overnight at 4 °C (see above). The coated TVs were blocked for 60 minutes with human milk supernatant after centrifugation of 5,000-10,000 rpm for 5 minutes. Cow milk and nonfat milk are not suitable blocking reagents for SNL lectin, as SNL recognizes unknown component(s) of cow milk. Biotinylated MAL or SNL lectin at 10 μ g/mL was incubated with coated TV for 60 minutes or longer time of overnight. The bound MAL or SNL lectin was detected by streptavidin-HRP conjugates (Jackson ImmunoResearch, West Grove, PA). The signal intensity was measured at OD 450 . The same fractions from a CsCl gradient of uninfected LLC-MK2 cells corresponding to the tested TV-containing fractions were used as negative controls.
Growth curves of TV with and without MAL treatment. The protocol for a single-cycle growth curve of TV was modified from a previous publication 49 . Briefly, LLC-MK2 cells in 6-well tissue culture plates (1 × 10 6 cells/well) were incubated with MAL (100 ug/mL/well in 1 × PBS) or 1 × PBS only at 37 °C in a CO 2 incubator on a rotary shaker for 60 minutes. 1 mL TV stock in 2x culture media (MOI = 1) was added to each well, and the cells were cultured further at 37 °C in a CO 2 incubator. , and Le y (Covance Inc., except the Mab against B antigen from Accurate Chemical and Scientific Corporation), at a final dilution of 1:100 at 37 °C for 60 min. FITC-conjugated goat anti-mouse IgG (Calbiochem Inc.) at a 1:400 dilution was applied for 60 minutes. Finally, the coverslips were stained with DAPI and mounted with Vectashield (Vector Laboratories). The stained cells were observed on an inverted fluorescent microscope, as described above.
Graph preparation and statistical analysis. Graphs were prepared using GraphPad Prism 6 (GraphPad Software, Inc.) and Excel 2010 (Microsoft Corporation). Statistical differences among data groups were analyzed in GraphPad Prism 6 using unpaired t-test. P values were set at 0.05 (P < 0.05) for significant difference (*), 0.01 (P < 0.01) for highly significant difference (**), and 0.001/0.0001 (P < 0.001/P < 0.0001) for extremely significant difference (***/****).
Results

TV interacts with SGCs in vitro.
Both huNoVs and TV are known to interact with HBGAs 6, 13 . Following our recent discovery that huNoVs also recognize SGCs 38 , we performed ELISA binding assays using purified TV virions and different synthetic SGCs. The results (Fig. 1) showed that TV bound strongly to the N-Acetylneuraminic acid (Neu5Ac or NANA) (P < 0.0001), and weakly to 6'-sialyllacNAc with a α -2,6 linked SA (P = 0.0011), but not to N-Glycolylneuraminic acid (Neu5Gc), 3'-sialylactose with a α -2,3 linked SA and a type A disaccharide GalNAc-Gal without a SA that served as negative controls. Two further controls were performed using the gradient faction of uninfected LLC-MK2 cell lysate corresponding to the purified TV fraction to bind Neu5Ac (cell ysis-Neu5Ac) and 6'-sialyllacNAc (cell ysis-6'-sialyllacNAc) (Fig. 1) . The negative results excluded the possibility of the observed binding signals from contaminated cellular proteins. A common feature of the binding SGCs is their SA residues, although the types, locations, and linkages of the SAs clearly affect the bindings. As positive controls, TV virions bound type B trisaccharide and recombinant HA protein of an H3N1 influenza virus bound strongly Neu5Ac (Neu5Ac-HA).
Neuraminidase treatment of host cells inhibited TV infectivity.
To further determine the biological significance of SAs in TV infection, TV-permissive LLC-MK2 cells were treated separately with two neuraminidases from Vibrio cholerae (VCNA) and Arthrobater ureafaciens (AUNA) prior to TV infection for plaque assays. Treatment with neuraminidases at 60 mU/well significantly reduced TV infection by 63.3% with VCNA ( Fig. 2A , P < 0.0001) and by 50.4% with AUNA ( Fig. 2B , P = 0.0012), compared to untreated cells. These results further support the importance of cell surface SAs in TV infection.
Effects of SA-binding lectins on TV infectivity. The role of cell surface SAs on TV infectivity in LLC-MK2 cells were assessed following treatment with two commonly used SA-binding lectins, Sambucus nigra lectin (SNL) or Maackia amurensis leukoagglutinin (MAL). SNL is known to bind α -2,6 linked SAs, while MAL binds α -2,3 linked SAs on SGCs 50 . As expected, SNL at 100 μ g/mL inhibited TV infection by ~32% (Fig. 3A , P = 0.0066), indicating that cell surface SGCs with α -2,6 linked SAs is important for TV infection. However, the low inhibition rate suggests that SGCs with SAs in other linkages also help TV infection. Surprisingly, MAL at the same concentration enhanced TV infection to 262% of the untreated control (P < 0.0001). Both SNL and MAL exhibited a dose-dependent response to TV infectivity (Fig. 3B,C) . While SNL reached the plateau of inhibition effects at 5 μ g/mL, MAL had the maximum enhancement effects at 50 μ g/mL. The lectin-enhancements of viral infection have been observed previously, including mannose-binding lectin (MBL) on Ebola virus 51 and galactose binding lectin-1 (Gal-1) on HIV 52 (see Discussion).
The MAL enhancement effects on TV infectivity were SA dependent. Since MAL is a SA binding lectin, we examined whether the enhancement effects of MAL on TV infectivity are SA dependent. As expected, treatment of LLC-MK2 cells with neuraminidase from Vibrio cholerae (VCNA) stopped the enhancement effects of MAL on TV infectivity, leading to a net reduction in TV infection, similar to the reduction observed after treatment of neuraminidase alone (Fig. 4) . These data indicate that the enhancement effects of MAL on TV infectivity rely on cell surface SAs.
MAL treatment resulted in steady increases in TV replication. To further understand the increased effects of MAL on TV infection and replication, we monitored TV replication over the first 28 hours after inoculation of LLC-MK2 cells with or without MAL treatment. Quantitative RT-PCR (qRT-PCR) showed increased TV RNA replication in MAL-treated compared with untreated cells at 4 hours post-inoculation (HPI) and the increase continued steadily for at least 28 HPI (Fig. 5A) . At 28 HPI, TV RNA levels in MAL-treated cells were 4.8 fold higher than those of untreated cells (Fig. 5B) . These data are consistent with the previous observation that MAL treatment enhanced TV infectivity. MAL may indirectly increase TV replication through the enhancement of virus binding/entry into cells.
TV can infect SGC-positive but HBGA-negative LLC-MK2 cells. TV binds B and
A type 3 antigens 13, 53 . When the HBGA expression patterns of LLC-MK2 cells were examined using a panel of monoclonal antibodies (Mabs) specific to A, B, H, Le , and Le y antigens, only B antigen was detected in a small number (<15%) of cells at any given time point (Fig. 6, data not shown) . On the other hand, the entire monolayer of LLC-MK2 cells was stained with fluorescein-labeled MAL or anti-GM1 antibody (Fig. 7A, data not shown) , indicating SGC expression on all these cells. Co-localization of B antigens and TV by immunofluorescence microscopy indicated that TV infection was not always correlated with the expression of B antigen on the cells. For example, both TV-uninfected but with strong B antigen expression and TV-infected but without B antigen expression were seen (Fig. 6) . On the other hand, all TV-infected cells appeared to be α ,2-3-linked SA-positive (Fig. 7) . Thus, TV can infect SGC-positive 
MAL interacted with TVs.
To further understand the mechanisms of the enhancement effects of MAL on TV replication, CsCl gradient-purified TV and corresponding fraction of cell lysate without TV was coated on plates and incubated with biotinylated MAL or SNL. Bound MAL, but not SNL was detected by streptavidin-HRP conjugates through ELISA (Fig. 8) . Marginal binding signals (OD 450 < 0.1) between the cell lysate fractions of uninfected LLC-MK2 cells and MAL were observed, which serve as a negative control. Thus, TV most likely interacts directly with MAL. Fig. 9A ), the bound MAL started to internalize into the cells (Fig. 9, B to F) . MAL tended to cluster in the cytoplasm around the nuclei. It remained detectable in cells for at least 18 hours (data not shown). This internalization may The mean values (plaque numbers) of the mock/control group were set as 100%, while percentages (%) of the plaque numbers for individual wells of both mock/control and neuraminidase-treatment groups relative to the mean values of the mock/control group were calculated and shown. The statistical differences between data groups are indicated. Each experiment was repeated at least eight times. (B and C) Dose-response effects of SNL and MAL at different concentrations on TV infectivity in LLC-MK2 cells. The mean value (plaque numbers) of the control group without SNL (B) or MAL (C) treatment (0 μ g/mL) was set 100%, while the reduction (B) or enhancement (C) rates (%) of the SNL/MAL treatment groups were calculated and shown. Each experiment was repeated at least four times. The statistical differences between the control groups (0 μ g/mL SNL/MAL) and the SNL/MAL treatment groups are indicated. "ns", "*", "**", and "***" indicate P values > 0.05, < 0.05, < 0.01, and < 0.001, respectively. help the entry of TV that bound to MAL into LLC-MK2 cells (see discussion). Similar dynamics of MAL internalization were also observed after incubation of MAL with MA-104 cells (Fig. 9, G to I ).
Rapid internalization of MAL into LLC-
Discussion
In this study, we provide the first evidence that TV recognizes SAs on cell surface SGCs based on multiple experiments with different approaches. In combination with the previously known TV-HBGA interactions 10, 13 , TV appears similar to huNoVs that can also recognize SAs and HBGAs 15, 38, 54 . Since huNoVs still cannot be cultivated in cell culture, TV would serve as a valuable surrogate to study the Several caliciviruses have been reported to recognize SA-containing SGCs, such as feline calicivirus (FCV) from the Vesivirus genus 46 ; porcine sapovirus (PSaV) from the Sapovirus genus 47 ; and murine (MNV) 48 and huNoVs 38 from the Norovirus genus. These data suggest that interaction with SGCs could be a common feature of caliciviruses. However, the unique feature of TV and huNoVs that they bind SGCs in addition to HBGAs, suggesting a mechanism involving two carbohydrate host factors in the Fluorescein-labeled MAL (green) was incubated with LLC-MK2 (A to F) or MA-104 (G to I) cells, and images were taken at different time points (15, 30, 45, 60, 120 , and 240 minutes post-incubation, MPI) using fluorescence microscopy to observe the dynamic changes of the bound MAL. Nuclei were stained with 4' ,6-diamidino-2-phenylindole (DAPI, blue). MAL was found to cluster in the cytoplasm of cells around 30 to 45 MPI. early stages of viral infection. Thus, further investigation to determine the potential coordinated roles of the two carbohydrate factors in the infection of TV and huNoVs (see below) is highly significant. TV appears to recognize SGCs with SAs in specific structures and linkages. For example, TV bound Neu5Ac-PAA, but not Neu5Gc-PAA, while the binding of TV to 6'-sialyllacNAc, with an α -2,6 linked-SA, is significantly stronger than binding to 3'-sialyllactose, with an α -2,3-linked SA. These specific interactions were supported through the blockade of TV infection of LLC-MK2 cells by SNL, a lectin that recognizes an α -2,6-linked SA. Further investigation into the interactions between TV and SGCs with an α -2,8 linked-SA or an internal SA is ongoing, which will help further understand the specific interactions between TV and SGCs. In a recent study, two huNoVs (GII.4 and GI.3) were reported to interact with gangliosides 38 , including GM3, GM2, and GM1a/b. The strongest binding affinity was to GM3, which has the same saccharide sequences as the 3'-sialyllactose used in this study. However, one should keep in mind that there may be a distinction between TV/huNoV binding to synthetic SGCs and cell surface SGC molecules. Therefore, while TV and huNoV share the common feature of interaction with SGCs, their interacting specificities may be different and this will need to be clarified through future studies.
The fact that TV and huNoV recognize both HBGAs and SGCs as host factors raises the question on how these two types of carbohydrates coordinate each other during TV/huNoV infection. In this regard, the cultivable TV would provide a useful model to study this issue. Previous studies showed that the type B HBGAs in human saliva and synthetic type B oligosaccharide were able to block TV replication 10, 13 , in which saliva had better blocking activity compared to synthetic oligosaccharides. In this study, we observed that neuraminidases and the SA-binding lectin (SNL) reduced TV infectivity, indicating that SGCs are also important for TV infection. However, it was noted that blocking or removal of either HBGAs or SGCs alone could not completely abolish TV infection, suggesting a possible complimentary effect for the two carbohydrates during TV infection. In fact, co-localization experiments of SGCs, HBGAs, and replicating TV in LLC-MK2 cells indicated that TV could infect LLC-MK2 cells without detectable B antigen, suggesting that the HBGA may not be absolutely required for TV infection in this cell line. This may also mean that the roles of HBGAs can be compensated for by SGCs at certain level during TV infection of LLC-MK2 cells.
However, the efficiency of TV infection through a single carbohydrate may be lower than that facilitated by both HBGAs and SGCs, because blocking either HBGAs or SGCs inhibited TV infectivity. Another possible explanation for the inhibition of TV infection by blocking either carbohydrate may be due to the close proximity of their two binding sites. As a result, blocking one binding site may also affect the function of the other binding site. This scenario may also explain the observation that type B saliva exhibited higher inhibitory effects compared to synthetic oligosaccharides containing the same type B antigen, because saliva is considered to have much larger molecules containing type B antigens than synthetic oligosaccharides.
Another major finding of this study is the enhancement of TV infection by MAL, an α -2,3 linked SA binding lectin derived from a tree species in the family Fabaceae. The enhancement effects of MAL apparently rely on cell surface SAs, because pretreatment of LLC-MK2 cells with neuraminidase wiped out the enhancement effects of MAL (Fig. 4) . In fact, our data showed that MAL is able to specifically bind both LLC-MK2 cells (Fig. 7) and TV (Fig. 8) . These special features allow MAL to recruit and enrich TV virions onto the host cell surfaces. After binding to host cells (LLC-MK2 and MA-104), MAL triggers internalization ( Fig. 9 ) and thus brings TV into the host cell cytoplasm in a highly efficient manner. This explains the enhancement of TV infectivity by MAL treatment. In contrast, due to the lack of interaction with TV ( Fig. 8) , SNL binds and blocks the α -2,6 linked SA-containing cell surface SGCs and thus inhibits TV infectivity (Fig. 3) . The enhancing effects of MAL in TV infectivity in the light of the dual binding of MAL to both cells and TV are unique. MAL is known to bind to cells in a high affinity via cell surface α -2,3 linked SAs. As a result, TV should bind to MAL via another domain that needs to be defined in the future.
Similar lectin-dependent enhancements of viral infectivity have been reported previously. For example, human mannose-binding lectin (MBL), a calcium-dependent (C-type) lectin that recognizes pathogen-specific surface glycans, was found to enhance Ebola virus (EBOV) infectivity under low complement conditions 51 . Mechanistic study demonstrated that MBL is able to bind both the N-linked glycan epitopes on EBOV surfaces and the transmembrane C-type lectin receptors on host cells 51 . Another example is the observation that galectin-1 promotes HIV-1 replication. Further study showed that the host-soluble galectin-1 is able to interact directly with glycans of the HIV envelope glycoprotein gp120 and CD4 on host cells 52 . In both cases, the lectins are able to recruit and enrich viruses to the surface of host cells, facilitating viral infection, a scenario similar to that for MAL observed in our study. However, unlike EBOV and HIV that are enveloped viruses with glycoproteins on the surface, TV is a nonenveloped virus that its capsid may or may not be glycosylated. Thus, how MAL interacts with TV remains to be studied in the future.
